BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16423412)

  • 1. Co-clustering activating and inhibitory receptors: impact at varying expression levels of the latter.
    Licht A; Abramson J; Pecht I
    Immunol Lett; 2006 Apr; 104(1-2):166-70. PubMed ID: 16423412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of mast cells' secretory response by co-clustering the Type 1 Fcepsilon receptor with the mast cell function-associated antigen.
    Licht A; Pecht I; Schweitzer-Stenner R
    Eur J Immunol; 2005 May; 35(5):1621-33. PubMed ID: 15827967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentalization of the Type I Fc epsilon receptor and MAFA on mast cell membranes.
    Barisas BG; Smith SM; Liu J; Song J; Hagen GM; Pecht I; Roess DA
    Biophys Chem; 2007 Mar; 126(1-3):209-17. PubMed ID: 16797115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable knockdown of MAFA expression in RBL-2H3 cells by siRNA retrovirus-delivery system.
    Abramson J; Rozenblum G; Pecht I
    Immunol Lett; 2004 Mar; 92(1-2):179-84. PubMed ID: 15081543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximity relationships between the type I receptor for Fc epsilon (Fc epsilon RI) and the mast cell function-associated antigen (MAFA) studied by donor photobleaching fluorescence resonance energy transfer microscopy.
    Jürgens L; Arndt-Jovin D; Pecht I; Jovin TM
    Eur J Immunol; 1996 Jan; 26(1):84-91. PubMed ID: 8566088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein tyrosine kinase syk activity is reduced by clustering the mast cell function-associated antigen.
    Xu R; Pecht I
    Eur J Immunol; 2001 May; 31(5):1571-81. PubMed ID: 11465115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the mast cell function-associated antigen with the type I Fcepsilon receptor.
    Song J; Hagen G; Smith SM; Roess DA; Pecht I; Barisas BG
    Mol Immunol; 2002 Sep; 38(16-18):1315-21. PubMed ID: 12217401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mast cell function-associated antigen and its interactions with the type I Fcepsilon receptor.
    Song J; Hagen GM; Roess DA; Pecht I; Barisas BG
    Biochemistry; 2002 Jan; 41(3):881-9. PubMed ID: 11790110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization of mast cells' secretory response to an immuno-receptor stimulus.
    Barbu AE; Pecht I
    Immunol Lett; 2005 Aug; 100(1):78-87. PubMed ID: 16111771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen.
    Xu R; Abramson J; Fridkin M; Pecht I
    J Immunol; 2001 Dec; 167(11):6394-402. PubMed ID: 11714805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell stimulation by co-clustering the type I Fc epsilon-receptors with mast cell function-associated antigens.
    Schweitzer-Stenner R; Engelke M; Licht A; Pecht I
    Immunol Lett; 1999 May; 68(1):71-8. PubMed ID: 10397158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
    Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
    Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IgE-dependent secretory response of mast cells can be induced by a glycosphingolipid-specific monoclonal antibody.
    Schwarz A; Jürgens L; Licht A; Schneider H; Futerman AH; Pecht I
    Eur J Immunol; 2000 Jan; 30(1):217-26. PubMed ID: 10602044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual inhibitory receptor--the mast cell function-associated antigen (MAFA).
    Abramson J; Xu R; Pecht I
    Mol Immunol; 2002 Sep; 38(16-18):1307-13. PubMed ID: 12217400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3.
    Okoshi Y; Tahara-Hanaoka S; Nakahashi C; Honda S; Miyamoto A; Kojima H; Nagasawa T; Shibuya K; Shibuya A
    Int Immunol; 2005 Jan; 17(1):65-72. PubMed ID: 15569773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering the mast cell function-associated antigen (MAFA) leads to tyrosine phosphorylation of p62Dok and SHIP and affects RBL-2H3 cell cycle.
    Abramson J; Pecht I
    Immunol Lett; 2002 Jun; 82(1-2):23-8. PubMed ID: 12008030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of Thy-1 glycoproteins or high-affinity IgE receptors induces mast cell activation via different mechanisms.
    Dráberová L; Dráber P
    Immunology; 1993 Sep; 80(1):103-9. PubMed ID: 7902332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering the mast cell function-associated antigen (MAFA) induces tyrosyl phosphorylation of the Fc epsilonRI-beta subunit.
    Rong X; Pecht I
    Immunol Lett; 1996 Dec; 54(2-3):105-8. PubMed ID: 9052862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions.
    Belostotsky R; Lorberboum-Galski H
    Clin Immunol; 2004 Jan; 110(1):89-99. PubMed ID: 14962800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mast cell function-associated antigen exhibits saccharide binding capacity.
    Binsack R; Pecht I
    Eur J Immunol; 1997 Oct; 27(10):2557-61. PubMed ID: 9368610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.